You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Viral Vector

Showing 1 - 25 of 4,437
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19, SARS-CoV-2 Infection Trial in Morelia (Recombinant COVID-19 variant Vaccine (Sf9 Cell), COVID-19 Vaccine (Vero Cell),

Not yet recruiting
  • COVID-19
  • SARS-CoV-2 Infection
  • Recombinant COVID-19 variant Vaccine (Sf9 Cell)
  • +3 more
  • Morelia, Michoacán De Ocampo, Mexico
    Clínica de Enfermedades Crónicas y de Procedimientos Especiales,
Jul 18, 2022

Hemophilia A Trial in Tianjin (Single dose intravenous injection of BBM-H803)

Recruiting
  • Hemophilia A
  • Single dose intravenous injection of BBM-H803
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital Chinese Academ
Oct 31, 2023

Hemophilia B Trial in United Kingdom, United States (Gene Transfer, scAAV2/8-LP1-hFIXco)

Active, not recruiting
  • Hemophilia B
  • Stanford, California
  • +7 more
Nov 17, 2022

Study in Subjects Who Received vMCO-I Administered Via

Enrolling by invitation
  • Retinitis Pigmentosa
  • +2 more
  • Gene Therapy product:vMCO-I
  • Cuttack, Odisha, India
    JPM Rotary Club of Cuttack Eye Hospital and Research Institute
Jun 26, 2023

LGMD2C Trial (ATA-200)

Not yet recruiting
  • LGMD2C
  • ATA-200
  • (no location specified)
Aug 1, 2023

Phenylketonuria Trial in Ankara (SAR444836)

Recruiting
  • Phenylketonuria
  • Ankara, Turkey
    Investigational Site Number: 7920001
Aug 7, 2023

Patients Who Received Gene-Modified Cell Therapy

Enrolling by invitation
  • Long-term Follow-up
  • Gene-Modified Cell Therapy
  • Philadelphia, Pennsylvania
    Abramson Cancer Center Clinical Research Unit, University of Pen
Jul 21, 2022

COVID-19, SARS-CoV-2 Infection Trial in Iloilo City (Recombinant COVID-19 Vaccine (Sf9 Cell), COVID-19 Vaccine (Vero Cell),

Recruiting
  • COVID-19
  • SARS-CoV-2 Infection
  • Recombinant COVID-19 Vaccine (Sf9 Cell)
  • COVID-19 Vaccine (Vero Cell), Inactivated
  • Iloilo City, Philippines
    Iloilo Doctors Hospital
Jul 18, 2022

Spinal Muscular Atrophy (SMA) Trial in Ekaterinburg, Moscow, Saint Petersburg (ANB-004, dose 1, ANB-004, dose 2, ANB-004, dose

Recruiting
  • Spinal Muscular Atrophy (SMA)
  • ANB-004, dose 1
  • +2 more
  • Ekaterinburg, Russian Federation
  • +5 more
Feb 17, 2023

Choroideremia Trial in Edmonton (rAAV2.REP1 vector)

Completed
  • Choroideremia
  • rAAV2.REP1 vector
  • Edmonton, Alberta, Canada
    University of Alberta
May 16, 2022

Squamous Cell Head Neck Cancer, Radiation Induced Xerostomia, Salivary Hypofunction Trial run by the (AAV2hAQP1)

Recruiting
  • Squamous Cell Head and Neck Cancer
  • +2 more
  • AAV2hAQP1
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
May 3, 2022

COVID-19 Trial in Vienna (Ad26COVS1, ChAdOx1 SARS2 Vaccine, BNT162B2)

Active, not recruiting
  • COVID-19
  • Vienna, Austria
    Medicial University of Vienna
Apr 12, 2022

Coronavirus Infection, COVID-19 Trial in Saint Petersburg (Low dose BCD-250 injection, High dose BCD-250 injection, Low dose or

Recruiting
  • Coronavirus Infection
  • COVID-19
  • Low dose BCD-250 injection
  • +3 more
  • Saint Petersburg, Russian Federation
  • +1 more
Sep 7, 2021

Study of AAV5-hFIX in Severe or Moderately Severe Haemophilia B

Active, not recruiting
  • Hemophilia B
  • AAV5-hFIX
  • Berlin, Germany
  • +5 more
Jan 17, 2023

Hemophilia B Trial in Worldwide (FLT180a)

Terminated
Has Results
  • Hemophilia B
  • FLT180a
  • Memphis, Tennessee
  • +10 more
Nov 8, 2022

Hemophilia B Trial in United States (AAV5-hFIXco-Padua (AMT-061))

Active, not recruiting
Has Results
  • Hemophilia B
  • AAV5-hFIXco-Padua (AMT-061)
  • Los Angeles, California
  • +3 more
May 17, 2022

SafeTy and Efficacy of Preventative CoVID Vaccines

Active, not recruiting
  • COVID-19 Virus Infection
  • Vaccine Response
  • mRNA Vaccines or Viral vector-based vaccines for COVID
  • Toronto, Ontario, Canada
    University Health Network
May 19, 2022

Hemophilia B Trial in Los Angeles (verbrinacogene setparvovec)

Recruiting
  • Hemophilia B
  • verbrinacogene setparvovec
  • Los Angeles, California
    Children's Hospital of Los Angeles
Jan 7, 2022

LGMDR9 Trial in Copenhagen, Paris, Newcastle Upon Tyne (GNT0006, Day 0: Placebo, Day 0: GNT0006)

Recruiting
  • LGMDR9
  • GNT0006
  • +4 more
  • Copenhagen, Denmark
  • +2 more
Oct 21, 2022

Hemophilia B Trial in Denmark, Germany, Netherlands (AAV5-hFIX)

Completed
Has Results
  • Hemophilia B
  • AAV5-hFIX
  • Copenhagen, Denmark
  • +6 more
Jun 1, 2022

Mucopolysaccharidosis Type VI Trial in Naples, Ankara (AAV2/8.TBG.hARSB)

Active, not recruiting
  • Mucopolysaccharidosis Type VI
  • AAV2/8.TBG.hARSB
  • Naples, Italy
  • +1 more
Nov 22, 2021

Subjects Who Received Voretigene Neparvovec-rzyl (AAV2-hRPE65v2)

Active, not recruiting
  • Inherited Retinal Dystrophy Due to RPE65 Mutations
  • AAV2-hRPE65v2
  • (no location specified)
Dec 9, 2021

Inherited Retinal Dystrophy Due to RPE65 Mutations, Leber Congenital Amaurosis Trial in Iowa City, Philadelphia

Active, not recruiting
Has Results
  • Inherited Retinal Dystrophy Due to RPE65 Mutations
  • Leber Congenital Amaurosis
  • AAV2-hRPE65v2,voretigene neparvovec-rzyl
  • Iowa City, Iowa
  • +1 more
Dec 9, 2021

Choroideremia, X-Linked Retinitis Pigmentosa Trial in Worldwide (BIIB111, BIIB112)

Enrolling by invitation
  • Choroideremia
  • X-Linked Retinitis Pigmentosa
  • BIIB111
  • BIIB112
  • Los Angeles, California
  • +22 more
Apr 20, 2022

Aromatic L-amino Acid Decarboxylase (AADC) Deficiency Trial in Taipei (gene therapy)

Active, not recruiting
  • Aromatic L-amino Acid Decarboxylase (AADC) Deficiency
  • gene therapy
  • Taipei, Taiwan
    National Taiwan University Hospital
Aug 4, 2021